Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Concord Biotech
(CONCORDBIO.NSE) Q3 2024
Earnings
CONCORDBIO.NSE
Aug 10
Confirmed
Q4 2023
Q2 2024
Q3 2024
5.74
6.85
7.97
9.09
Details
Expected EPS
6.54101435715
Actual EPS
5.73596643627
Surprise EPS
-0.81
Surprise Percent
-12.31%
Description
Concord Biotech (CONCORDBIO.NSE) has reported earnings of 5.73596643627 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login